Drugs / HGP1201
Trials 3
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 13 trials | ||||||
| Phase 1 | NCT02715401 | Oct → Nov 2015 | benign prostatic hyperplasia, erectile dysfunction | Hanmi Pharmaceutical Company Limited | Completed | No outcome recorded |
| Phase 1 | NCT02712411 | Jul → Aug 2015 | erectile dysfunction, prostate disorder | Hanmi Pharmaceutical Company Limited | Completed | No outcome recorded |
| Phase 1 | NCT02243319 | Sep → Dec 2014 | — | Hanmi Pharmaceutical Company Limited | Completed | No outcome recorded |
| Comparator or background therapy1 trial | ||||||
| Phase 3 | NCT02667938 Comparator | Mar 2015 → Jan 2016 | benign prostatic hyperplasia | Hanmi Pharmaceutical Company Limited | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 4 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | HGP1201 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02667938 ↗ |